
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Current Challenges of Cardiac Amyloidosis Awareness among Romanian Cardiologists - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="8E59B3CB925F99033AB3CB0033321586.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="diagno">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8148147/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Diagnostics">
<meta name="citation_title" content="Current Challenges of Cardiac Amyloidosis Awareness among Romanian Cardiologists">
<meta name="citation_author" content="Robert Adam">
<meta name="citation_author_institution" content="Expert Center for Rare Genetic Cardiovascular Diseases, Department of Cardiology, “Prof. Dr. C.C. Iliescu” Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania; gabriela.neculae94@gmail.com (G.N.); ruxandra.jurcut@umfcd.ro (R.J.)">
<meta name="citation_author_institution" content="“Carol Davila” University of Medicine and Pharmacy, 030167 Bucharest, Romania; claudiu.stan@drd.umfcd.ro">
<meta name="citation_author" content="Gabriela Neculae">
<meta name="citation_author_institution" content="Expert Center for Rare Genetic Cardiovascular Diseases, Department of Cardiology, “Prof. Dr. C.C. Iliescu” Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania; gabriela.neculae94@gmail.com (G.N.); ruxandra.jurcut@umfcd.ro (R.J.)">
<meta name="citation_author" content="Claudiu Stan">
<meta name="citation_author_institution" content="“Carol Davila” University of Medicine and Pharmacy, 030167 Bucharest, Romania; claudiu.stan@drd.umfcd.ro">
<meta name="citation_author_institution" content="Department of Nuclear Medicine and Ultrasonography, Fundeni Clinical Institute, 022328 Bucharest, Romania">
<meta name="citation_author" content="Ruxandra Jurcut">
<meta name="citation_author_institution" content="Expert Center for Rare Genetic Cardiovascular Diseases, Department of Cardiology, “Prof. Dr. C.C. Iliescu” Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania; gabriela.neculae94@gmail.com (G.N.); ruxandra.jurcut@umfcd.ro (R.J.)">
<meta name="citation_author_institution" content="“Carol Davila” University of Medicine and Pharmacy, 030167 Bucharest, Romania; claudiu.stan@drd.umfcd.ro">
<meta name="citation_publication_date" content="2021 May 6">
<meta name="citation_volume" content="11">
<meta name="citation_issue" content="5">
<meta name="citation_firstpage" content="834">
<meta name="citation_doi" content="10.3390/diagnostics11050834">
<meta name="citation_pmid" content="34066384">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8148147/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8148147/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8148147/pdf/diagnostics-11-00834.pdf">
<meta name="description" content="Cardiac amyloidosis (CA) is a restrictive cardiomyopathy characterized by deposition of amyloid in the myocardium and recent studies revealed it is more frequently seen than we thought. Advances in diagnosis and treatment have been made over the ...">
<meta name="og:title" content="Current Challenges of Cardiac Amyloidosis Awareness among Romanian Cardiologists">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Cardiac amyloidosis (CA) is a restrictive cardiomyopathy characterized by deposition of amyloid in the myocardium and recent studies revealed it is more frequently seen than we thought. Advances in diagnosis and treatment have been made over the ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8148147/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="8148147">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3390/diagnostics11050834"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/diagnostics-11-00834.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8148147%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/8148147/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/8148147/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8148147/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-diagno.png" alt="Diagnostics logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Diagnostics" title="Link to Diagnostics" shape="default" href="http://www.mdpi.com/journal/diagnostics" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Diagnostics (Basel)</button></div>. 2021 May 6;11(5):834. doi: <a href="https://doi.org/10.3390/diagnostics11050834" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3390/diagnostics11050834</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Diagnostics%20(Basel)%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Diagnostics%20(Basel)%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Diagnostics%20(Basel)%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Diagnostics%20(Basel)%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Current Challenges of Cardiac Amyloidosis Awareness among Romanian Cardiologists</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Adam%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Robert Adam</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Robert Adam</span></h3>
<div class="p">
<sup>1</sup>Expert Center for Rare Genetic Cardiovascular Diseases, Department of Cardiology, “Prof. Dr. C.C. Iliescu” Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania; gabriela.neculae94@gmail.com (G.N.); ruxandra.jurcut@umfcd.ro (R.J.)</div>
<div class="p">
<sup>2</sup>“Carol Davila” University of Medicine and Pharmacy, 030167 Bucharest, Romania; claudiu.stan@drd.umfcd.ro</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Adam%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Robert Adam</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>*,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Neculae%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Gabriela Neculae</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Gabriela Neculae</span></h3>
<div class="p">
<sup>1</sup>Expert Center for Rare Genetic Cardiovascular Diseases, Department of Cardiology, “Prof. Dr. C.C. Iliescu” Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania; gabriela.neculae94@gmail.com (G.N.); ruxandra.jurcut@umfcd.ro (R.J.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Neculae%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Gabriela Neculae</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stan%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Claudiu Stan</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Claudiu Stan</span></h3>
<div class="p">
<sup>2</sup>“Carol Davila” University of Medicine and Pharmacy, 030167 Bucharest, Romania; claudiu.stan@drd.umfcd.ro</div>
<div class="p">
<sup>3</sup>Department of Nuclear Medicine and Ultrasonography, Fundeni Clinical Institute, 022328 Bucharest, Romania</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stan%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Claudiu Stan</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jurcut%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Ruxandra Jurcut</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Ruxandra Jurcut</span></h3>
<div class="p">
<sup>1</sup>Expert Center for Rare Genetic Cardiovascular Diseases, Department of Cardiology, “Prof. Dr. C.C. Iliescu” Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania; gabriela.neculae94@gmail.com (G.N.); ruxandra.jurcut@umfcd.ro (R.J.)</div>
<div class="p">
<sup>2</sup>“Carol Davila” University of Medicine and Pharmacy, 030167 Bucharest, Romania; claudiu.stan@drd.umfcd.ro</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jurcut%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Ruxandra Jurcut</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>
</div>
<div class="cg p">Editor: <span class="name western">Stefano Perlini</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af1-diagnostics-11-00834">
<sup>1</sup>Expert Center for Rare Genetic Cardiovascular Diseases, Department of Cardiology, “Prof. Dr. C.C. Iliescu” Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania; gabriela.neculae94@gmail.com (G.N.); ruxandra.jurcut@umfcd.ro (R.J.)</div>
<div id="af2-diagnostics-11-00834">
<sup>2</sup>“Carol Davila” University of Medicine and Pharmacy, 030167 Bucharest, Romania; claudiu.stan@drd.umfcd.ro</div>
<div id="af3-diagnostics-11-00834">
<sup>3</sup>Department of Nuclear Medicine and Ultrasonography, Fundeni Clinical Institute, 022328 Bucharest, Romania</div>
<div class="author-notes p">
<div class="fn" id="c1-diagnostics-11-00834">
<sup>*</sup><p class="display-inline">Correspondence: <span>robert.adam@drd.umfcd.ro</span>; Tel.: +40-213-175-221</p>
</div>
<div class="fn" id="fn1-diagnostics-11-00834">
<sup>†</sup><p class="display-inline">Current Address: “Prof. Dr. C.C. Iliescu” Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania; 3rd Cardiology Department, 258 Fundeni Street, 022328 Bucharest, Romania.</p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Stefano Perlini</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2021 Mar 24; Accepted 2021 May 4; Collection date 2021 May.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2021 by the authors.</div>
<p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by/4.0/</a>).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC8148147  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34066384/" class="usa-link">34066384</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Cardiac amyloidosis (CA) is a restrictive cardiomyopathy characterized by deposition of amyloid in the myocardium and recent studies revealed it is more frequently seen than we thought. Advances in diagnosis and treatment have been made over the last few years that make it desirable to diagnose CA without delay, and that may require extra education. An online survey was conducted among cardiologists from Romania, representing the first assessment of the knowledge of CA among them, with 195 cardiologists answering the questionnaire. There was a wide variation in their knowledge regarding CA. Our participants had limited experience with CA and reported a significant delay between first cardiac symptoms and diagnosis. We address the gaps in knowledge that were identified as educational opportunities in the main identified areas: prevalence and treatment of wild type transthyretin amyloidosis (ATTRwt), prevalence of variant transthyretin amyloidosis (ATTRv) in Romania, diagnosis of CA, the delay in CA diagnosis and available treatment options. Awareness among cardiologists is the most important challenge in diagnosing CA. Romanian cardiologists are partially aware of this topic, but there are still gaps in their knowledge. Educational programs can improve screening of patients with a high suspicion for this progressive condition the prognosis of which has been dramatically changed by the new treatment options.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> amyloidosis, cardiologist, awareness, survey, ATTR</p></section></section><section id="sec1-diagnostics-11-00834"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Cardiac amyloidosis (CA) is a restrictive cardiomyopathy characterized by deposition of amyloid which is represented by misfolded proteins in the myocardial interstitium [<a href="#B1-diagnostics-11-00834" class="usa-link" aria-describedby="B1-diagnostics-11-00834">1</a>]. The most important classification of systemic amyloidosis is based on the amyloid precursor and although to date there are 36 types of proteins described as precursors [<a href="#B2-diagnostics-11-00834" class="usa-link" aria-describedby="B2-diagnostics-11-00834">2</a>], CA is determined in most of the cases by two: immunoglobulin light chains and transthyretin.</p>
<p>If the amyloid precursor is represented by misfolded immunoglobulin light chains the disease is called light chain amyloidosis (AL) which is a multisystem disease involving almost any organ and system: soft tissues, cardiovascular system, kidneys, peripheral nervous system, liver or lungs [<a href="#B3-diagnostics-11-00834" class="usa-link" aria-describedby="B3-diagnostics-11-00834">3</a>]. AL is a rare disease with a reported incidence of approximately 9–14 cases per million person-years [<a href="#B4-diagnostics-11-00834" class="usa-link" aria-describedby="B4-diagnostics-11-00834">4</a>,<a href="#B5-diagnostics-11-00834" class="usa-link" aria-describedby="B5-diagnostics-11-00834">5</a>].</p>
<p>Transthyretin amyloidosis (ATTR) results from the accumulation of transthyretin amyloid in the extracellular space of different organs and systems, most commonly in the heart and peripheral nervous system [<a href="#B6-diagnostics-11-00834" class="usa-link" aria-describedby="B6-diagnostics-11-00834">6</a>]. Normal transthyretin is a tetrameric plasma protein which is responsible for the transportation of thyroid hormones, particularly thyroxine and retinol-binding protein [<a href="#B7-diagnostics-11-00834" class="usa-link" aria-describedby="B7-diagnostics-11-00834">7</a>]. ATTR manifests as variant ATTR (ATTRv, previously known as hereditary or mutant ATTR) or as wild-type ATTR (ATTRwt, previously known as senile systemic amyloidosis) [<a href="#B8-diagnostics-11-00834" class="usa-link" aria-describedby="B8-diagnostics-11-00834">8</a>].</p>
<p>ATTRv results from pathogenic mutations in transthyretin gene with an autosomal dominant inheritance pattern and its overall prevalence in Europe is estimated to be less than 1 in 100,000 individuals [<a href="#B7-diagnostics-11-00834" class="usa-link" aria-describedby="B7-diagnostics-11-00834">7</a>,<a href="#B8-diagnostics-11-00834" class="usa-link" aria-describedby="B8-diagnostics-11-00834">8</a>]. ATTRv is a heterogenous disorder and its multiorgan involvement and clinical presentation is determined by the pathogenic transthyretin gene mutation: neurological phenotypes, cardiac phenotypes or mixed phenotypes [<a href="#B9-diagnostics-11-00834" class="usa-link" aria-describedby="B9-diagnostics-11-00834">9</a>].</p>
<p>Distinct from ATTRv, ATTRwt is mainly an isolated CA but it can also affect the soft tissues and the peripheral nervous system leading to bilateral carpal tunnel syndrome or spinal stenosis [<a href="#B10-diagnostics-11-00834" class="usa-link" aria-describedby="B10-diagnostics-11-00834">10</a>]. ATTRwt is considered a marker of ageing and commonly affects men older than 60 years [<a href="#B11-diagnostics-11-00834" class="usa-link" aria-describedby="B11-diagnostics-11-00834">11</a>].</p>
<p>As endomyocardial biopsy involves certain risks and may not always be available and the extracardiac biopsy may miss a significant number of patients [<a href="#B12-diagnostics-11-00834" class="usa-link" aria-describedby="B12-diagnostics-11-00834">12</a>], a non-invasive algorithm [<a href="#B13-diagnostics-11-00834" class="usa-link" aria-describedby="B13-diagnostics-11-00834">13</a>] represents a valuable alternative to cardiac biopsy for CA by detecting features strongly suggestive of amyloidosis. According to this diagnostic algorithm every patient with a high suspicion of CA should undergo two procedures: a bone-avid, phosphate-based isotope scintigraphy (bone scan) and a search for signs of plasma cell dyscrasia; a positive bone scan combined with the absence of plasma cell dyscrasia sign can diagnose ATTR with specificity and positive predictive value of 100% [<a href="#B13-diagnostics-11-00834" class="usa-link" aria-describedby="B13-diagnostics-11-00834">13</a>].</p>
<p>Nowadays an increase in the prevalence of CA can be described, particularly in ATTR, as we are witnessing an aged population, an increase in the accuracy of the non-invasive diagnostic algorithm, as well as an increase in the therapeutic options which may require a more accurate diagnosis [<a href="#B8-diagnostics-11-00834" class="usa-link" aria-describedby="B8-diagnostics-11-00834">8</a>,<a href="#B14-diagnostics-11-00834" class="usa-link" aria-describedby="B14-diagnostics-11-00834">14</a>]. Given that CA was considered a rare disease and requires a multidisciplinary team, most cardiologists do not have the clinical expertise for diagnosing or treating this disease so misdiagnosis or delayed diagnosis are common. Additionally, despite the revolution in CA treatment with significant advances in the novel therapies, there is a significant number of cardiologists who still believe that this disease has no pathogenic treatment and the only available therapy is represented by the supportive treatment.</p>
<p>In a study involving 1034 patients with CA from the UK National Amyloidosis Centre with a subset of 534 patients in whom complete data on hospital service usage were available, there was a median diagnostic delay from the first presentation with cardiac symptoms of 39 (8–78) months in patients with ATTRwt, with 42% waiting more than 4 years for the diagnosis to be established and a median delay of 25 (4–60) months in the ATTRv group [<a href="#B15-diagnostics-11-00834" class="usa-link" aria-describedby="B15-diagnostics-11-00834">15</a>]. Another retrospective study involving 270 consecutive patients with CA diagnosed at Toulouse University Hospital reported a median delay between symptoms onset and diagnosis of 8 (5–14), 10 (3–34) and 18 (4–49) months in AL, ATTRwt and ATTRv, respectively, where patients encountered a median number of 2 (1–7) physicians and performed a median number of 3 (1–8) tests before the diagnosis [<a href="#B16-diagnostics-11-00834" class="usa-link" aria-describedby="B16-diagnostics-11-00834">16</a>].</p>
<p>We performed a survey of the practicing cardiologists from Romania in order to assess their awareness regarding the epidemiology, diagnosis and available treatment options of cardiac amyloidosis, and how this reflects in their practice.</p></section><section id="sec2-diagnostics-11-00834"><h2 class="pmc_sec_title">2. Materials and Methods</h2>
<p>An online survey was conducted among cardiologists from all healthcare centers in Romania in a time interval of 2 months, between 1 September and 31 October 2020. It contained 26 single or multiple choice questions developed by the authors which covered participants’ general data (working place and experience in the field), clinical expertise and particular expertise with CA. The questionnaire was developed based on the authors’ experience, current amyloidosis related consensus documents as well as existing recommendations for survey design [<a href="#B17-diagnostics-11-00834" class="usa-link" aria-describedby="B17-diagnostics-11-00834">17</a>,<a href="#B18-diagnostics-11-00834" class="usa-link" aria-describedby="B18-diagnostics-11-00834">18</a>]. A complete copy of the online questionnaire is available in the “<a href="#app1-diagnostics-11-00834" class="usa-link">Supplementary File</a>”. The survey was introduced on a dedicated platform for online questionnaires and was distributed to a list of cardiologists available to the Romanian Society of Cardiology via email and through social media. The total number of cardiologist members of the Romanian Society of Cardiology is 1475, among which 430 are in training. All participants could respond to the questionnaire only once. Survey participation was anonymous and voluntary and participants were aware that authors were planning to publish the results, thus ethical approval was not required. Data were collected after 2 months and presented as percentages from the total answers.</p></section><section id="sec3-diagnostics-11-00834"><h2 class="pmc_sec_title">3. Results</h2>
<section id="sec3dot1-diagnostics-11-00834"><h3 class="pmc_sec_title">3.1. Survey Participants</h3>
<p>One-hundred and ninety five Romanian cardiologists answered the online questionnaire. More than half of them (123 participants, 63%) were from three large centers which are distributed symmetrically in the country (Bucharest: 74 participants, 38%; Iasi: 30 participants, 15% and Cluj: 19 participants, 10%). The majority of the participants are working in a University Center (71% vs. 29%) with most of them working on the cardiology ward of a public hospital (139 participants, 72%) followed by private outpatient clinics (29 participants, 15%). The median time for completion of the online questionnaire was 7 min and 41 s with a minimum of 1 min and 58 s and a maximum of 11 h and 39 min. Of the 194 participants who answered this question the majority (178 participants, 92%) described their role as clinical cardiologists, with approximately one third of the participants being subspecialized in: cardiovascular imaging (35 participants, 18%), interventional angiography (12 participants, 6%), heart failure (7 participants, 4%), arrhythmology (4 participants, 2%), rare cardiovascular diseases (3 participants, 1.5%) and other subspecialities (10 participants, 5%). Regarding the training, there was an approximately equal distribution between the three levels of training in Romania: cardiologists in training (65 participants, 33%), specialized cardiologists (60 participants, 31%) and senior cardiologists (70 participants, 36%). The estimated weekly number of patients treated by our surveyed cardiologists is presented in <a href="#diagnostics-11-00834-f001" class="usa-link">Figure 1</a>A.</p>
<figure class="fig xbox font-sm" id="diagnostics-11-00834-f001"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8148147_diagnostics-11-00834-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1a/8148147/8dd081b4308b/diagnostics-11-00834-g001.jpg" loading="lazy" height="314" width="793" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/diagnostics-11-00834-f001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) Number of general cardiology weekly patients treated by surveyed cardiologists. (<strong>B</strong>) Number of patients presenting with cardiac amyloidosis managed by cardiologists answering the survey.</p></figcaption></figure></section><section id="sec3dot2-diagnostics-11-00834"><h3 class="pmc_sec_title">3.2. Experience with Cardiac Amyloidosis Patients</h3>
<p>Almost three quarters of the respondents (141 cardiologists, 72%) stated they had diagnosed or cared for patients with CA in their careers. However, most of the responding cardiologists have little expertise with CA, and very few of them have significant expertise with this disease (<a href="#diagnostics-11-00834-f001" class="usa-link">Figure 1</a>B). The most common type of amyloidosis seen in our participants practice was AL, followed by ATTR and AA (<a href="#diagnostics-11-00834-f002" class="usa-link">Figure 2</a>A). The majority of our participants (82%) appreciated the mean delay from the first presentation with cardiac symptoms to diagnosis was between 0 and 24 months and only 10% reported a diagnostic delay of more than 36 months (<a href="#diagnostics-11-00834-f002" class="usa-link">Figure 2</a>B).</p>
<figure class="fig xbox font-sm" id="diagnostics-11-00834-f002"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8148147_diagnostics-11-00834-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1a/8148147/3d044a13d012/diagnostics-11-00834-g002.jpg" loading="lazy" height="315" width="791" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/diagnostics-11-00834-f002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) Most frequently seen etiologies of cardiac amyloidosis in the clinical practice of the surveyed cardiologists. (<strong>B</strong>) Mean delay from the first presentation with cardiac symptoms to diagnosis of cardiac amyloidosis reported by the surveyed cardiologists.</p></figcaption></figure></section><section id="sec3dot3-diagnostics-11-00834"><h3 class="pmc_sec_title">3.3. Cardiac Amyloidosis Diagnostic Workup</h3>
<p>CA was labeled as a rare disease by approximately three quarters of our surveyed cardiologists (73%). In their view, the main systems and organs affected by systemic amyloidosis were: cardiovascular (99%), renal (85%), peripheral (61%) and autonomic (54%) nervous system, digestive (46%), eyes (14%) and respiratory system (8%). The clinical features of heart failure (HF) that would raise the suspicion of a possible diagnosis of CA in our participants are shown in <a href="#diagnostics-11-00834-t001" class="usa-link">Table 1</a>.</p>
<section class="tw xbox font-sm" id="diagnostics-11-00834-t001"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Clinical features of heart failure that would raise the suspicion of a possible diagnosis of cardiac amyloidosis in our participants; EF—ejection fraction, HF—heart failure, LVH—left ventricular hypertrophy.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Answers</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Participants</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Percentage of Participants</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Preserved or reduced EF according to the ESC guidelines for heart failure</td>
<td align="center" valign="middle" rowspan="1" colspan="1">140</td>
<td align="center" valign="middle" rowspan="1" colspan="1">73%</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">History of bilateral carpal tunnel syndrome</td>
<td align="center" valign="middle" rowspan="1" colspan="1">133</td>
<td align="center" valign="middle" rowspan="1" colspan="1">69%</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Sensory or motor neuropathy</td>
<td align="center" valign="middle" rowspan="1" colspan="1">133</td>
<td align="center" valign="middle" rowspan="1" colspan="1">69%</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Postural hypotension</td>
<td align="center" valign="middle" rowspan="1" colspan="1">130</td>
<td align="center" valign="middle" rowspan="1" colspan="1">68%</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Nephrotic syndrome</td>
<td align="center" valign="middle" rowspan="1" colspan="1">115</td>
<td align="center" valign="middle" rowspan="1" colspan="1">60%</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Macroglossia</td>
<td align="center" valign="middle" rowspan="1" colspan="1">102</td>
<td align="center" valign="middle" rowspan="1" colspan="1">53%</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Digestive motility disorders</td>
<td align="center" valign="middle" rowspan="1" colspan="1">93</td>
<td align="center" valign="middle" rowspan="1" colspan="1">48%</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">HF symptoms with poor response or worsening to standard HF treatment</td>
<td align="center" valign="middle" rowspan="1" colspan="1">84</td>
<td align="center" valign="middle" rowspan="1" colspan="1">44%</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Spontaneous cutaneous ecchymosis</td>
<td align="center" valign="middle" rowspan="1" colspan="1">81</td>
<td align="center" valign="middle" rowspan="1" colspan="1">42%</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Advanced age</td>
<td align="center" valign="middle" rowspan="1" colspan="1">72</td>
<td align="center" valign="middle" rowspan="1" colspan="1">38%</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Severe aortic stenosis and severe, unexplained LVH on imaging</td>
<td align="center" valign="middle" rowspan="1" colspan="1">70</td>
<td align="center" valign="middle" rowspan="1" colspan="1">37%</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Difficulty urinating</td>
<td align="center" valign="middle" rowspan="1" colspan="1">30</td>
<td align="center" valign="middle" rowspan="1" colspan="1">16%</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lumbar spinal stenosis</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12%</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/diagnostics-11-00834-t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>When specifically questioned on wtATTR, most respondents stated it is a multisystem disease (62%); 35% of cardiologists believe it has a genetic cause and 30% said it can be observed only in people older than 70 years. Almost one half of the respondents know that it can also be identified in a significant proportion of patients with heart failure with preserved ejection fraction (HFpEF) or severe aortic stenosis (48%) and one third of them stated there is no disease modifying treatment available for ATTRwt.</p>
<p>Diagnostic tests considered by our participants in patients with HF and suspicion of CA are shown in <a href="#diagnostics-11-00834-f003" class="usa-link">Figure 3</a>. When asked about the changes which are mandatorily seen in CA the majority of our participants (45%) answered there are no obligatory changes. Among the other answers, the following hallmarks of CA were chosen as mandatory: restrictive filling pattern (33%), apical sparing pattern on speckle tracking echocardiography (29%), low voltage on electrocardiography (ECG) (28%), concentric left ventricular hypertrophy (LVH) (24%), maximum wall thickness (MWT) of at least 15 mm (21%), postural hypotension (10%), anterior pseudoinfarction on ECG (8%), pericardial effusion (6%) and carpal tunnel syndrome (4%). ECG and echocardiographic features of CA are presented in <a href="#diagnostics-11-00834-f004" class="usa-link">Figure 4</a>A,B, respectively. When needing to distinguish between the two main types of CA, the preferred investigations were immunofixation and light chain assay (55%), genetic tests (53%) and bone scintigraphy (48%). Other answers were: endomyocardial biopsy (19%), extracardiac biopsy (18%), cardiac magnetic resonance (CMR) (13%), echocardiography (3%) and ECG (2%).</p>
<figure class="fig xbox font-sm" id="diagnostics-11-00834-f003"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8148147_diagnostics-11-00834-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1a/8148147/9a960a6548f4/diagnostics-11-00834-g003.jpg" loading="lazy" height="515" width="724" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/diagnostics-11-00834-f003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Diagnostic tests considered by the survey participants in patients with heart failure and suspicion of cardiac amyloidosis. CMR cardiac magnetic resonance, ECG electrocardiogram, LC light chain. Cardiac biomarkers are represented by NT-pro BNP and troponin.</p></figcaption></figure><figure class="fig xbox font-sm" id="diagnostics-11-00834-f004"><h4 class="obj_head">Figure 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8148147_diagnostics-11-00834-g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1a/8148147/5f946b7ff734/diagnostics-11-00834-g004.jpg" loading="lazy" height="266" width="748" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/diagnostics-11-00834-f004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) Electrocardiographic hallmarks of cardiac amyloidosis chosen by the survey participants. (<strong>B</strong>) Echocardiographic hallmarks of cardiac amyloidosis chosen by the survey participants. LV—left ventricle.</p></figcaption></figure></section><section id="sec3dot4-diagnostics-11-00834"><h3 class="pmc_sec_title">3.4. Cardiac Amyloidosis Therapy Awareness</h3>
<p>In the event of treating patients with suspected CA, 92% of the participants responded they would refer these patients to an expert center, only 22% stated they would initiate the specific treatment and a further 7% said they would continue the HF treatment and would not refer these patients as they did not see the need for further investigations because there is no specific treatment for patients with CA. When asked about HF treatment in this disease most of them had chosen either loop diuretic (75%) or mineralocorticoid receptor antagonists (60%), but a significant proportion stated they would treat these patients with betablockers (46%) and angiotensin converting enzyme inhibitors (57%) (<a href="#diagnostics-11-00834-f005" class="usa-link">Figure 5</a>). Regarding the disease modifying treatment options most of them had chosen chemotherapy for AL (75%) and tafamidis (73%) or patisiran (35%) for ATTR. Other answers were chemotherapy for ATTR (9%), and tafamidis (8%) or patisiran (9%) for AL (8%).</p>
<figure class="fig xbox font-sm" id="diagnostics-11-00834-f005"><h4 class="obj_head">Figure 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8148147_diagnostics-11-00834-g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1a/8148147/f0d4ea6c7563/diagnostics-11-00834-g005.jpg" loading="lazy" height="527" width="791" alt="Figure 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/diagnostics-11-00834-f005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Participants’ options for heart failure treatment in patients with cardiac amyloidosis. ACEi—angiotensin converting enzyme inhibitor; ARB—angiotensin receptor blocker; ICD—implantable cardioverter defibrillator.</p></figcaption></figure></section></section><section id="sec4-diagnostics-11-00834"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>This survey was conducted at a time when the field of knowledge in cardiomyopathies in general and in CA in particular is in a continuous and rapid development, but the awareness still needs to be improved. As a response to this development of knowledge a scientific statement from the American Heart Association [<a href="#B19-diagnostics-11-00834" class="usa-link" aria-describedby="B19-diagnostics-11-00834">19</a>] and a position paper from the European Society of Cardiology working group on myocardial and pericardial diseases [<a href="#B20-diagnostics-11-00834" class="usa-link" aria-describedby="B20-diagnostics-11-00834">20</a>] were published in 2020 and 2021, respectively, by experts in this field. Other important societies, such as the Canadian [<a href="#B21-diagnostics-11-00834" class="usa-link" aria-describedby="B21-diagnostics-11-00834">21</a>] and German [<a href="#B22-diagnostics-11-00834" class="usa-link" aria-describedby="B22-diagnostics-11-00834">22</a>] ones recently published their position statements regarding this disease. Unfortunately, there has been no consensus document published by the Romanian Society of Cardiology in this field until now and the diagnosis and management of these patients are based on the European Society of Cardiology and other international societies’ guidelines and recommendations, which the Romanian Society endorses.</p>
<p>This is the first assessment of the knowledge regarding CA among Romanian cardiologists, which highlighted that one of the most important challenges in the diagnosis of CA is awareness. We found a wide variation in cardiologists knowledge regarding CA in general, as well as diagnostic tests and treatment options. The gaps in knowledge should be addressed as educational opportunities in the main identified areas: prevalence and treatment of ATTRwt, prevalence of ATTRv in Romania, diagnosis of CA, the delay in CA diagnosis and available treatment options.</p>
<section id="sec4dot1-diagnostics-11-00834"><h3 class="pmc_sec_title">4.1. Prevalence and Treatment of ATTRwt</h3>
<p>In our survey, both CA in general and ATTRwt were perceived as a rare disease. Moreover, one third of our participants answered ATTRwt can only be observed in people older than 70 years, and only one half of them said that it can be identified in a significant proportion of patients with HFpEF or severe aortic stenosis. However, contrary to common belief, CA is no longer considered a rare disease. Recent studies revealed that ATTRwt can even be considered a common disease, but its prevalence remains to be established. One of the first studies which raised the awareness of this disease was an autopsy study conducted in Finland that showed cardiac transthyretin deposits in nearly one quarter of the 256 subjects older than 85 years [<a href="#B23-diagnostics-11-00834" class="usa-link" aria-describedby="B23-diagnostics-11-00834">23</a>]. Furthermore, the presence of ATTRwt was not only clinically described in 13% of HFpEF patients above 60 years old and with LVH of more than 12 mm [<a href="#B24-diagnostics-11-00834" class="usa-link" aria-describedby="B24-diagnostics-11-00834">24</a>], but also histologically described in 14% of the patients with HFpEF enrolled in a more recent study which prospectively evaluated 108 endomyocardial biopsies [<a href="#B25-diagnostics-11-00834" class="usa-link" aria-describedby="B25-diagnostics-11-00834">25</a>].</p>
<p>Other recent studies demonstrated concomitant ATTRwt in a significant proportion of patients with HFpEF and severe aortic stenosis, with a prevalence of 6–8% in patients with severe aortic stenosis requiring surgical aortic valve replacement [<a href="#B26-diagnostics-11-00834" class="usa-link" aria-describedby="B26-diagnostics-11-00834">26</a>,<a href="#B27-diagnostics-11-00834" class="usa-link" aria-describedby="B27-diagnostics-11-00834">27</a>] and a prevalence of 13–16% in patients with severe aortic stenosis referred for transcatheter aortic valve replacement [<a href="#B28-diagnostics-11-00834" class="usa-link" aria-describedby="B28-diagnostics-11-00834">28</a>,<a href="#B29-diagnostics-11-00834" class="usa-link" aria-describedby="B29-diagnostics-11-00834">29</a>].</p>
<p>Respondents stated that there is no disease modifying treatment available for ATTRwt, which is currently not correct, as tafamidis was associated with reductions in all-cause mortality and cardiovascular-related hospitalizations and reduced the decline in functional capacity and quality of life as compared with placebo in ATTR-CA patients, and ATTRwt represented three quarters of the ATTRACT study population [<a href="#B30-diagnostics-11-00834" class="usa-link" aria-describedby="B30-diagnostics-11-00834">30</a>].</p></section><section id="sec4dot2-diagnostics-11-00834"><h3 class="pmc_sec_title">4.2. Prevalence of ATTRv in Romania</h3>
<p>In Romania, a specific mutation with regional distribution for ATTRv (Glu54Gln) was discovered a decade ago [<a href="#B31-diagnostics-11-00834" class="usa-link" aria-describedby="B31-diagnostics-11-00834">31</a>] and fully characterized more recently [<a href="#B32-diagnostics-11-00834" class="usa-link" aria-describedby="B32-diagnostics-11-00834">32</a>]. In the latest publication the authors stated 23 patients have been diagnosed with ATTRv in Romania, 18 of whom had the Glu54Gln mutation which is characterized by early disease onset, mixed phenotype (both cardiac and neurological involvement), aggressive disease progression and short survival [<a href="#B32-diagnostics-11-00834" class="usa-link" aria-describedby="B32-diagnostics-11-00834">32</a>]. Another important finding was that all these 18 patients have origins in the North-Eastern region of Romania (Suceava County) where a cluster of ATTRv patients has been identified [<a href="#B32-diagnostics-11-00834" class="usa-link" aria-describedby="B32-diagnostics-11-00834">32</a>]. They also reported a prevalence of ATTRv of 1.02 per 1,000,000 people in the general Romanian population with 2.39 per 100,000 people in Suceava County and stated that prevalence of this disease in Romania is substantially underestimated due to several factors, including lack of access to or refusal to receive medical care and limited survival of these patients [<a href="#B32-diagnostics-11-00834" class="usa-link" aria-describedby="B32-diagnostics-11-00834">32</a>].</p>
<p>Improving knowledge among cardiologists regarding this mixed phenotype form of ATTRv in Romania is of importance, as it can facilitate the timely recognition of this disease in patients who combine LV hypertrophy and sensory–motor neuropathy, especially if originating from this geographical area.</p></section><section id="sec4dot3-diagnostics-11-00834"><h3 class="pmc_sec_title">4.3. CA Diagnosis</h3>
<section id="sec4dot3dot1-diagnostics-11-00834"><h4 class="pmc_sec_title">4.3.1. Diagnostic Delay</h4>
<p>The majority of our participants stated the mean delay from the first presentation with cardiac symptoms to diagnosis was no longer than 24 months, which is significantly lower than it was previously described in a large study involving patients from the UK National Amyloidosis Centre where a median diagnostic delay of 39 months was reported [<a href="#B15-diagnostics-11-00834" class="usa-link" aria-describedby="B15-diagnostics-11-00834">15</a>], but consistent with the results from another study involving patients with CA diagnosed at Toulouse University Hospital which reported a median delay between symptom onset and diagnosis of 8, 10 and 18 months in AL, ATTRwt and ATTRv, respectively [<a href="#B16-diagnostics-11-00834" class="usa-link" aria-describedby="B16-diagnostics-11-00834">16</a>]. Only proper training of healthcare personnel can improve the diagnostic delay in this condition as early diagnosis combined with timely initiation of the disease modifying treatment may lead to disease stabilization and a significant improvement in patient status [<a href="#B19-diagnostics-11-00834" class="usa-link" aria-describedby="B19-diagnostics-11-00834">19</a>]. For cardiologists, a shortening of the diagnostic delay could be obtained by providing education on the diagnostic tools and the clinical scenarios which characterize CA especially in the early phases, as discussed below. In order to promote proper testing and referrals among general practitioners, who are typically the first point of contact for a newly symptomatic patient, Gertz et al. recently published expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner [<a href="#B33-diagnostics-11-00834" class="usa-link" aria-describedby="B33-diagnostics-11-00834">33</a>].</p></section><section id="sec4dot3dot2-diagnostics-11-00834"><h4 class="pmc_sec_title">4.3.2. Diagnostic Tools</h4>
<p>Timely diagnosis relies on high clinical suspicion, knowledge of cardiac and extracardiac red flags and correct use of diagnostic algorithms. In our survey, around two thirds of cardiologists recognized postural hypotension, neuropathy and carpal tunnel syndrome as red flags for amyloidosis. However, only 53% of respondents mentioned macroglossia and somewhat more than one third would suspect amyloidosis in severe aortic stenosis patients with excessive LVH. Systemic manifestations are frequently seen in ATTR: bilateral sensory–motor polyneuropathy starting in the lower limbs with an ascending pattern and orthostatic hypotension may be present in ATTRv; bilateral carpal tunnel syndrome, lumbar spinal stenosis, and biceps tendon rupture are all common extracardiac manifestations in ATTRwt [<a href="#B34-diagnostics-11-00834" class="usa-link" aria-describedby="B34-diagnostics-11-00834">34</a>]. Of note, bilateral carpal tunnel syndrome is not only the most common noncardiac manifestation, but can precede clinical HF by several years [<a href="#B35-diagnostics-11-00834" class="usa-link" aria-describedby="B35-diagnostics-11-00834">35</a>]. A recent study found it present in approximately half of ATTRwt patients 5 to 7 years before diagnosis [<a href="#B36-diagnostics-11-00834" class="usa-link" aria-describedby="B36-diagnostics-11-00834">36</a>]. While macroglossia is present in 10–15% of AL amyloidosis cases, it has been reported also in few cases of ATTR as well [<a href="#B37-diagnostics-11-00834" class="usa-link" aria-describedby="B37-diagnostics-11-00834">37</a>].</p>
<p>Interestingly, 59% of cardiologists still rely on extracardiac biopsy and 28% on endomyocardial biopsy in the CA diagnostic workup. However, it is known that the diagnostic yield of fat pad aspirate is only 45% in ATTRv and 15% in ATTRwt [<a href="#B12-diagnostics-11-00834" class="usa-link" aria-describedby="B12-diagnostics-11-00834">12</a>]. Moreover, a correct and timely CA diagnosis can be based on a non-invasive algorithm [<a href="#B13-diagnostics-11-00834" class="usa-link" aria-describedby="B13-diagnostics-11-00834">13</a>] which is able to detect suggestive features of CA without the invasive nature and associated risks of endomyocardial biopsy. An essential knowledge for the cardiologist should hence be that every patient with a high suspicion of CA should undergo two procedures: a bone-avid, phosphate-based isotope scintigraphy and a plasma cell dyscrasia workup [<a href="#B13-diagnostics-11-00834" class="usa-link" aria-describedby="B13-diagnostics-11-00834">13</a>]. Following these two procedures, only if the bone scintigraphy is negative and the search for plasma cell dyscrasia is positive is the extracardiac biopsy needed to confirm the amyloid deposition and to establish the AL diagnosis. In this situation CMR is also very useful to confirm the infiltration of the heart [<a href="#B20-diagnostics-11-00834" class="usa-link" aria-describedby="B20-diagnostics-11-00834">20</a>]. In the absence of a detectable monoclonal protein the sensitivity and specificity of a bone scintigraphy (grade 2 or grade 3) for ATTR has been proposed to be almost 100% [<a href="#B13-diagnostics-11-00834" class="usa-link" aria-describedby="B13-diagnostics-11-00834">13</a>] so there is no need for a histological confirmation of amyloid deposits in this case. If the cardiac uptake is grade 1, non-invasive diagnosis is not possible and the histological confirmation and identification of amyloid deposits is required, followed by CMR confirmation of cardiac infiltration if an extracardiac biopsy was used [<a href="#B20-diagnostics-11-00834" class="usa-link" aria-describedby="B20-diagnostics-11-00834">20</a>].</p>
<p>Survey participants were aware of the clinical scenarios and red flags which should raise the suspicion of this condition as well as the diagnostic tests which are needed to establish the final diagnosis, but only half of them know how to distinguish between the two main types of CA using the non-invasive diagnostic algorithm based on the bone scintigraphy and the search for plasma cell dyscrasia [<a href="#B13-diagnostics-11-00834" class="usa-link" aria-describedby="B13-diagnostics-11-00834">13</a>]. According to a trend toward multimodality imaging education in the last few years, 86% of cardiologists would chose CMR in the diagnostic workup, as compared to only 54% bone scintigraphy.</p>
<p>Surveyed cardiologists appeared to be aware of the ECG and echocardiographic hallmarks of CA in accordance with the current data from the literature [<a href="#B38-diagnostics-11-00834" class="usa-link" aria-describedby="B38-diagnostics-11-00834">38</a>]. Furthermore, many cardiologists consider that several features are mandatory in CA on which they can rely for the diagnosis. This is a misconception, as Gonzalez-Lopez et al. showed in a study published in 2017 involving 108 patients with ATTRwt that the clinical spectrum of this disease is heterogeneous and it appears that there is no reliable classic phenotype [<a href="#B10-diagnostics-11-00834" class="usa-link" aria-describedby="B10-diagnostics-11-00834">10</a>].</p></section><section id="sec4dot3dot3-diagnostics-11-00834"><h4 class="pmc_sec_title">4.3.3. Therapeutic Options</h4>
<p>The treatment of systemic amyloidosis has dramatically evolved over the last few years in both AL and ATTR, improving disease prognosis. However, treating CA associated HF is a complex task due to the frequent association between systemic congestion and low blood pressure, thromboembolic and hemorrhagic risk balance, patient frailty and poor prognosis. Diuretics represent the first line of medical treatment in HF and CA, which is also reflected in the respondents’ views. However, the cardiologists’ answers in our survey also included betablockers (46%) and vasodilators (57%) as possible therapeutic options, probably extrapolating from conventional HF therapy. However, betablockers are not well tolerated in restrictive cardiomyopathies in general, and CA in particular, while due to sometimes severe postural hypotension, vasodilators have also a very restricted use [<a href="#B19-diagnostics-11-00834" class="usa-link" aria-describedby="B19-diagnostics-11-00834">19</a>,<a href="#B20-diagnostics-11-00834" class="usa-link" aria-describedby="B20-diagnostics-11-00834">20</a>]. Anticoagulation was deemed necessary by 24% of the respondents; this is in line with the concepts that CA is often associated with biatrial enlargement and atrial fibrillation, but also that patients with CA present a high frequency of intracardiac thrombosis, especially those with the AL type, even in the presence of sinus rhythm and preserved systolic function, likely because of a poor atrial function [<a href="#B39-diagnostics-11-00834" class="usa-link" aria-describedby="B39-diagnostics-11-00834">39</a>].</p>
<p>The main advancements in CA therapy come from the development of TTR stabilizers (e.g., Tafamidis) and TTR protein silencers (e.g., patisiran, inotersen). In the ATTR-ACT randomized trial including patients with ATTRwt or ATTRv CA, tafamidis was associated with a significantly lower all-cause mortality (29.5% versus 42.9%) and lower cardiovascular-related hospitalization (0.48 versus 0.70 per year) after 30 months [<a href="#B30-diagnostics-11-00834" class="usa-link" aria-describedby="B30-diagnostics-11-00834">30</a>] compared to placebo. Subsequently, a study which aimed to assess the clinical characteristics of ATTR in a real-life population was published by the group of the French national center for CA and showed an association between tafamidis treatment and a lower occurrence of cardiovascular outcomes [<a href="#B40-diagnostics-11-00834" class="usa-link" aria-describedby="B40-diagnostics-11-00834">40</a>]. Other therapeutical options are represented by genetic silencers such as patisiran, which improved multiple clinical manifestations of ATTRv [<a href="#B41-diagnostics-11-00834" class="usa-link" aria-describedby="B41-diagnostics-11-00834">41</a>] or inotersen which improved the course of neurologic disease and quality of life in patients with ATTRv [<a href="#B42-diagnostics-11-00834" class="usa-link" aria-describedby="B42-diagnostics-11-00834">42</a>] in phase 3 clinical studies. The latest European recommendations stated that tafamidis should be generally considered the agent of choice in ATTR cardiac patients with reasonable expected survival, while patisiran could be considered in ATTRv patients with cardiac involvement in whom gene silencers are prescribed due to symptomatic neurological disease [<a href="#B20-diagnostics-11-00834" class="usa-link" aria-describedby="B20-diagnostics-11-00834">20</a>]. Almost three quarters of Romanian cardiologists have knowledge of Tafamidis as a specific therapy for ATTR associated CA (73%), while less than one third (35%) consider patisiran an option in this setting, which is in accordance with the more scarce data supporting this. There is, however, confusion for some cardiologists between the available therapeutic options, with 8% of the respondents believing that these drugs also treat AL amyloidosis.</p>
<p>Conversely, specific treatment in cardiac AL amyloidosis is recommended to be undertaken by multidisciplinary teams involving oncohaematology and cardiology specialists and, whenever possible, patients should be referred to specialized centers [<a href="#B20-diagnostics-11-00834" class="usa-link" aria-describedby="B20-diagnostics-11-00834">20</a>]. The discovery of bortezomib represented a treatment revolution in achieving rapid hematological responses in patients with AL [<a href="#B43-diagnostics-11-00834" class="usa-link" aria-describedby="B43-diagnostics-11-00834">43</a>]. The most commonly used first-line treatment is represented by a combination of three drugs—cyclophosphamide, the reversible proteasome inhibitor bortezomib and steroids such as dexamethasone (CyBorD), with weekly administration.</p>
<p>We strongly believe that appropriate education and patients’ screening should now be mandatory to optimize patient care, especially with the significant progress made in this disease’s diagnosis and treatment.</p></section></section></section><section id="sec5-diagnostics-11-00834"><h2 class="pmc_sec_title">5. Study Limitations</h2>
<p>This is a small size survey designed to provide information regarding current knowledge on CA among cardiologists from Romania. An important limitation of this study could be that only a small proportion of Romanian cardiologists answered the survey, therefore the results may not be representative of all heart specialists from Romania. However, our respondents were from both academic and non-academic health institutions, covering equally all three stages of training and all of our country’s geographic areas, making this an illustrative sample of medical professionals with relevant answers.</p></section><section id="sec6-diagnostics-11-00834"><h2 class="pmc_sec_title">6. Conclusions</h2>
<p>Awareness among cardiologists is the most important challenge in diagnosing CA. Romanian cardiologists are partially aware of this topic, but several misconceptions and gaps in knowledge exist. Therefore, more educational efforts are needed regarding the latest concepts. This can improve the clinical suspicion, with timely access to screening algorithms for this rapidly progressive condition whose evolution has been dramatically changed by the new treatment options.</p></section><section id="app1-diagnostics-11-00834" class="app"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<p>The copy of the complete online questionnaire is available online at <a href="https://www.mdpi.com/article/10.3390/diagnostics11050834/s1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.mdpi.com/article/10.3390/diagnostics11050834/s1</a>.</p>
<section class="sm xbox font-sm" id="diagnostics-11-00834-s001"><div class="media p"><div class="caption">
<a href="/articles/instance/8148147/bin/diagnostics-11-00834-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (73.1KB, zip) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>Conceptualization, R.A. and R.J.; methodology, R.A. and R.J.; software, R.A. and R.J.; formal analysis, R.A. and R.J.; investigation, R.A. and R.J.; writing—original draft preparation, R.A.; writing—review and editing, R.A., G.N., C.S. and R.J.; visualization, R.A., G.N., C.S. and R.J.; supervision, R.J. All authors have read and agreed to the published version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported by an unrestricted educational work from the Pfizer competitive grant program under grant contract no 2480/14.05.2020.</p></section><section id="notes3"><h2 class="pmc_sec_title">Institutional Review Board Statement</h2>
<p>Not applicable.</p></section><section id="notes4"><h2 class="pmc_sec_title">Informed Consent Statement</h2>
<p>Not applicable.</p></section><section id="notes5"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The data presented in this study are available on request from the corresponding author.</p></section><section id="notes6"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>Ruxandra Jurcut reports speaker fees and unrestricted grants from Pfizer, non-competing with the present work. The authors report no other conflicts of interest in this work.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn2"><p><strong>Publisher’s Note:</strong> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1-diagnostics-11-00834">
<span class="label">1.</span><cite>Siddiqi O.K., Ruberg F.L. Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment. Trends Cardiovasc. Med. 2018;28:10–21. doi: 10.1016/j.tcm.2017.07.004.</cite> [<a href="https://doi.org/10.1016/j.tcm.2017.07.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5741539/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28739313/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Cardiovasc.%20Med.&amp;title=Cardiac%20amyloidosis:%20An%20update%20on%20pathophysiology,%20diagnosis,%20and%20treatment&amp;author=O.K.%20Siddiqi&amp;author=F.L.%20Ruberg&amp;volume=28&amp;publication_year=2018&amp;pages=10-21&amp;pmid=28739313&amp;doi=10.1016/j.tcm.2017.07.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2-diagnostics-11-00834">
<span class="label">2.</span><cite>Sipe J.D., Benson M.D., Buxbaum J.N., Ikeda S.I., Merlini G., Saraiva M.J., Westmark P. Amyloid fibril proteins and amyloidosis: Chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines. Amyloid. 2016;23:209–213. doi: 10.1080/13506129.2016.1257986.</cite> [<a href="https://doi.org/10.1080/13506129.2016.1257986" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27884064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Amyloid%20fibril%20proteins%20and%20amyloidosis:%20Chemical%20identification%20and%20clinical%20classification%20International%20Society%20of%20Amyloidosis%202016%20Nomenclature%20Guidelines&amp;author=J.D.%20Sipe&amp;author=M.D.%20Benson&amp;author=J.N.%20Buxbaum&amp;author=S.I.%20Ikeda&amp;author=G.%20Merlini&amp;volume=23&amp;publication_year=2016&amp;pages=209-213&amp;pmid=27884064&amp;doi=10.1080/13506129.2016.1257986&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3-diagnostics-11-00834">
<span class="label">3.</span><cite>Falk R.H., Alexander K.M., Liao R., Dorbala S. AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy. J. Am. Coll. Cardiol. 2016;68:1323–1341. doi: 10.1016/j.jacc.2016.06.053.</cite> [<a href="https://doi.org/10.1016/j.jacc.2016.06.053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27634125/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Coll.%20Cardiol.&amp;title=AL%20(Light-Chain)%20Cardiac%20Amyloidosis:%20A%20Review%20of%20Diagnosis%20and%20Therapy&amp;author=R.H.%20Falk&amp;author=K.M.%20Alexander&amp;author=R.%20Liao&amp;author=S.%20Dorbala&amp;volume=68&amp;publication_year=2016&amp;pages=1323-1341&amp;pmid=27634125&amp;doi=10.1016/j.jacc.2016.06.053&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4-diagnostics-11-00834">
<span class="label">4.</span><cite>Quock T.P., Yan T., Chang E., Guthrie S., Broder M.S. Epidemiology of AL amyloidosis: A real-world study using US claims data. Blood Adv. 2018;2:1046–1053. doi: 10.1182/bloodadvances.2018016402.</cite> [<a href="https://doi.org/10.1182/bloodadvances.2018016402" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5965052/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29748430/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood%20Adv.&amp;title=Epidemiology%20of%20AL%20amyloidosis:%20A%20real-world%20study%20using%20US%20claims%20data&amp;author=T.P.%20Quock&amp;author=T.%20Yan&amp;author=E.%20Chang&amp;author=S.%20Guthrie&amp;author=M.S.%20Broder&amp;volume=2&amp;publication_year=2018&amp;pages=1046-1053&amp;pmid=29748430&amp;doi=10.1182/bloodadvances.2018016402&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5-diagnostics-11-00834">
<span class="label">5.</span><cite>Duhamel S., Mohty D., Magne J., Lavergne D., Bordessoule D., Aboyans V., Jaccard A. Incidence and Prevalence of Light Chain Amyloidosis: A Population-Based Study. Blood. 2017;130(Suppl. 1):5577.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Incidence%20and%20Prevalence%20of%20Light%20Chain%20Amyloidosis:%20A%20Population-Based%20Study&amp;author=S.%20Duhamel&amp;author=D.%20Mohty&amp;author=J.%20Magne&amp;author=D.%20Lavergne&amp;author=D.%20Bordessoule&amp;volume=130&amp;issue=Suppl.%201&amp;publication_year=2017&amp;pages=5577&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6-diagnostics-11-00834">
<span class="label">6.</span><cite>Ruberg F.L., Berk J.L. Transthyretin (TTR) cardiac amyloidosis. Circulation. 2012;126:1286–1300. doi: 10.1161/CIRCULATIONAHA.111.078915.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.111.078915" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3501197/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22949539/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Transthyretin%20(TTR)%20cardiac%20amyloidosis&amp;author=F.L.%20Ruberg&amp;author=J.L.%20Berk&amp;volume=126&amp;publication_year=2012&amp;pages=1286-1300&amp;pmid=22949539&amp;doi=10.1161/CIRCULATIONAHA.111.078915&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7-diagnostics-11-00834">
<span class="label">7.</span><cite>Gonzalez-Lopez E., Lopez-Sainz A., Garcia-Pavia P. Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope. Rev. Esp. Cardiol. 2017;70:991–1004. doi: 10.1016/j.recesp.2017.05.018.</cite> [<a href="https://doi.org/10.1016/j.recesp.2017.05.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28870641/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rev.%20Esp.%20Cardiol.&amp;title=Diagnosis%20and%20Treatment%20of%20Transthyretin%20Cardiac%20Amyloidosis.%20Progress%20and%20Hope&amp;author=E.%20Gonzalez-Lopez&amp;author=A.%20Lopez-Sainz&amp;author=P.%20Garcia-Pavia&amp;volume=70&amp;publication_year=2017&amp;pages=991-1004&amp;pmid=28870641&amp;doi=10.1016/j.recesp.2017.05.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8-diagnostics-11-00834">
<span class="label">8.</span><cite>Rapezzi C., Lorenzini M., Longhi S., Milandri A., Gagliardi C., Bartolomei I.I., Salvi F., Maurer M.S. Cardiac amyloidosis: The great pretender. Heart Fail. Rev. 2015;20:117–124. doi: 10.1007/s10741-015-9480-0.</cite> [<a href="https://doi.org/10.1007/s10741-015-9480-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25758359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heart%20Fail.%20Rev.&amp;title=Cardiac%20amyloidosis:%20The%20great%20pretender&amp;author=C.%20Rapezzi&amp;author=M.%20Lorenzini&amp;author=S.%20Longhi&amp;author=A.%20Milandri&amp;author=C.%20Gagliardi&amp;volume=20&amp;publication_year=2015&amp;pages=117-124&amp;pmid=25758359&amp;doi=10.1007/s10741-015-9480-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9-diagnostics-11-00834">
<span class="label">9.</span><cite>Maurer M.S., Hanna M., Grogan M., Dispenzieri A., Witteles R., Drachman B., Judge D.P., Lenihan D.J., Gottlieb S.S., Shah S.J., et al.  Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey) J. Am. Coll. Cardiol. 2016;68:161–172. doi: 10.1016/j.jacc.2016.03.596.</cite> [<a href="https://doi.org/10.1016/j.jacc.2016.03.596" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4940135/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27386769/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Coll.%20Cardiol.&amp;title=Genotype%20and%20Phenotype%20of%20Transthyretin%20Cardiac%20Amyloidosis:%20THAOS%20(Transthyretin%20Amyloid%20Outcome%20Survey)&amp;author=M.S.%20Maurer&amp;author=M.%20Hanna&amp;author=M.%20Grogan&amp;author=A.%20Dispenzieri&amp;author=R.%20Witteles&amp;volume=68&amp;publication_year=2016&amp;pages=161-172&amp;pmid=27386769&amp;doi=10.1016/j.jacc.2016.03.596&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10-diagnostics-11-00834">
<span class="label">10.</span><cite>Gonzalez-Lopez E., Gagliardi C., Dominguez F., Quarta C.C., de Haro-Del Moral F.J., Milandri A., Salas C., Cinelli M., Cobo-Marcos M., Lorenzini M., et al.  Clinical characteristics of wild-type transthyretin cardiac amyloidosis: Disproving myths. Eur. Heart J. 2017;38:1895–1904. doi: 10.1093/eurheartj/ehx043.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehx043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28329248/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Clinical%20characteristics%20of%20wild-type%20transthyretin%20cardiac%20amyloidosis:%20Disproving%20myths&amp;author=E.%20Gonzalez-Lopez&amp;author=C.%20Gagliardi&amp;author=F.%20Dominguez&amp;author=C.C.%20Quarta&amp;author=F.J.%20de%20Haro-Del%20Moral&amp;volume=38&amp;publication_year=2017&amp;pages=1895-1904&amp;pmid=28329248&amp;doi=10.1093/eurheartj/ehx043&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11-diagnostics-11-00834">
<span class="label">11.</span><cite>Grogan M., Scott C.G., Kyle R.A., Zeldenrust S.R., Gertz M.A., Lin G., Klarich K.W., Miller W.L., Maleszewski J.J., Dispenzieri A. Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System. J. Am. Coll. Cardiol. 2016;68:1014–1020. doi: 10.1016/j.jacc.2016.06.033.</cite> [<a href="https://doi.org/10.1016/j.jacc.2016.06.033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27585505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Coll.%20Cardiol.&amp;title=Natural%20History%20of%20Wild-Type%20Transthyretin%20Cardiac%20Amyloidosis%20and%20Risk%20Stratification%20Using%20a%20Novel%20Staging%20System&amp;author=M.%20Grogan&amp;author=C.G.%20Scott&amp;author=R.A.%20Kyle&amp;author=S.R.%20Zeldenrust&amp;author=M.A.%20Gertz&amp;volume=68&amp;publication_year=2016&amp;pages=1014-1020&amp;pmid=27585505&amp;doi=10.1016/j.jacc.2016.06.033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12-diagnostics-11-00834">
<span class="label">12.</span><cite>Quarta C.C., Gonzalez-Lopez E., Gilbertson J.A., Botcher N., Rowczenio D., Petrie A., Rezk T., Youngstein T., Mahmood S., Sachchithanantham S., et al.  Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis. Eur. Heart J. 2017;38:1905–1908. doi: 10.1093/eurheartj/ehx047.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehx047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5837229/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28605421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Diagnostic%20sensitivity%20of%20abdominal%20fat%20aspiration%20in%20cardiac%20amyloidosis&amp;author=C.C.%20Quarta&amp;author=E.%20Gonzalez-Lopez&amp;author=J.A.%20Gilbertson&amp;author=N.%20Botcher&amp;author=D.%20Rowczenio&amp;volume=38&amp;publication_year=2017&amp;pages=1905-1908&amp;pmid=28605421&amp;doi=10.1093/eurheartj/ehx047&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13-diagnostics-11-00834">
<span class="label">13.</span><cite>Gillmore J.D., Maurer M.S., Falk R.H., Merlini G., Damy T., Dispenzieri A., Wechalekar A.D., Berk J.L., Quarta C.C., Grogan M., et al.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016;133:2404–2412. doi: 10.1161/CIRCULATIONAHA.116.021612.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.116.021612" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27143678/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Nonbiopsy%20Diagnosis%20of%20Cardiac%20Transthyretin%20Amyloidosis&amp;author=J.D.%20Gillmore&amp;author=M.S.%20Maurer&amp;author=R.H.%20Falk&amp;author=G.%20Merlini&amp;author=T.%20Damy&amp;volume=133&amp;publication_year=2016&amp;pages=2404-2412&amp;pmid=27143678&amp;doi=10.1161/CIRCULATIONAHA.116.021612&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14-diagnostics-11-00834">
<span class="label">14.</span><cite>Emdin M., Aimo A., Rapezzi C., Fontana M., Perfetto F., Seferovic P.M., Barison A., Castiglione V., Vergaro G., Giannoni A., et al.  Treatment of cardiac transthyretin amyloidosis: An update. Eur. Heart J. 2019;40:3699–3706. doi: 10.1093/eurheartj/ehz298.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehz298" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31111153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Treatment%20of%20cardiac%20transthyretin%20amyloidosis:%20An%20update&amp;author=M.%20Emdin&amp;author=A.%20Aimo&amp;author=C.%20Rapezzi&amp;author=M.%20Fontana&amp;author=F.%20Perfetto&amp;volume=40&amp;publication_year=2019&amp;pages=3699-3706&amp;pmid=31111153&amp;doi=10.1093/eurheartj/ehz298&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15-diagnostics-11-00834">
<span class="label">15.</span><cite>Lane T., Fontana M., Martinez-Naharro A., Quarta C.C., Whelan C.J., Petrie A., Rowczenio D.M., Gilbertson J.A., Hutt D.F., Rezk T., et al.  Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis. Circulation. 2019;140:16–26. doi: 10.1161/CIRCULATIONAHA.118.038169.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.118.038169" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31109193/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Natural%20History,%20Quality%20of%20Life,%20and%20Outcome%20in%20Cardiac%20Transthyretin%20Amyloidosis&amp;author=T.%20Lane&amp;author=M.%20Fontana&amp;author=A.%20Martinez-Naharro&amp;author=C.C.%20Quarta&amp;author=C.J.%20Whelan&amp;volume=140&amp;publication_year=2019&amp;pages=16-26&amp;pmid=31109193&amp;doi=10.1161/CIRCULATIONAHA.118.038169&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16-diagnostics-11-00834">
<span class="label">16.</span><cite>Dang D., Fournier P., Cariou E., Huart A., Ribes D., Cintas P., Roussel M., Colombat M., Lavie-Badie Y., Carrie D., et al.  Gateway and journey of patients with cardiac amyloidosis. ESC Heart Fail. 2020;7:2418–2430. doi: 10.1002/ehf2.12793.</cite> [<a href="https://doi.org/10.1002/ehf2.12793" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7524246/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32588554/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ESC%20Heart%20Fail.&amp;title=Gateway%20and%20journey%20of%20patients%20with%20cardiac%20amyloidosis&amp;author=D.%20Dang&amp;author=P.%20Fournier&amp;author=E.%20Cariou&amp;author=A.%20Huart&amp;author=D.%20Ribes&amp;volume=7&amp;publication_year=2020&amp;pages=2418-2430&amp;pmid=32588554&amp;doi=10.1002/ehf2.12793&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17-diagnostics-11-00834">
<span class="label">17.</span><cite>Gaur P.S., Zimba O., Agarwal V., Gupta L. Reporting Survey Based Studies-a Primer for Authors. J. Korean Med. Sci. 2020;35:e398. doi: 10.3346/jkms.2020.35.e398.</cite> [<a href="https://doi.org/10.3346/jkms.2020.35.e398" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7683244/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33230988/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Korean%20Med.%20Sci.&amp;title=Reporting%20Survey%20Based%20Studies-a%20Primer%20for%20Authors&amp;author=P.S.%20Gaur&amp;author=O.%20Zimba&amp;author=V.%20Agarwal&amp;author=L.%20Gupta&amp;volume=35&amp;publication_year=2020&amp;pages=e398&amp;pmid=33230988&amp;doi=10.3346/jkms.2020.35.e398&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18-diagnostics-11-00834">
<span class="label">18.</span><cite>Haugaa K.H., Marsan N.A., Cameli M., D’Andrea A., Dweck M.R., Carvalho R.F., Holte E., Manka R., Michalski B., Podlesnikar T., et al.  Criteria for surveys: From the European Association of Cardiovascular Imaging Scientific Initiatives Committee. Eur. Heart J. Cardiovasc. Imaging. 2019;20:963–966. doi: 10.1093/ehjci/jez193.</cite> [<a href="https://doi.org/10.1093/ehjci/jez193" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31436816/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.%20Cardiovasc.%20Imaging&amp;title=Criteria%20for%20surveys:%20From%20the%20European%20Association%20of%20Cardiovascular%20Imaging%20Scientific%20Initiatives%20Committee&amp;author=K.H.%20Haugaa&amp;author=N.A.%20Marsan&amp;author=M.%20Cameli&amp;author=A.%20D%E2%80%99Andrea&amp;author=M.R.%20Dweck&amp;volume=20&amp;publication_year=2019&amp;pages=963-966&amp;pmid=31436816&amp;doi=10.1093/ehjci/jez193&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19-diagnostics-11-00834">
<span class="label">19.</span><cite>Kittleson M.M., Maurer M.S., Ambardekar A.V., Bullock-Palmer R.P., Chang P.P., Eisen H.J., Nair A.P., Nativi-Nicolau J., Ruberg F.L. Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement from the American Heart Association. Circulation. 2020;142:e7–e22. doi: 10.1161/CIR.0000000000000792.</cite> [<a href="https://doi.org/10.1161/CIR.0000000000000792" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32476490/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Cardiac%20Amyloidosis:%20Evolving%20Diagnosis%20and%20Management:%20A%20Scientific%20Statement%20from%20the%20American%20Heart%20Association&amp;author=M.M.%20Kittleson&amp;author=M.S.%20Maurer&amp;author=A.V.%20Ambardekar&amp;author=R.P.%20Bullock-Palmer&amp;author=P.P.%20Chang&amp;volume=142&amp;publication_year=2020&amp;pages=e7-e22&amp;pmid=32476490&amp;doi=10.1161/CIR.0000000000000792&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20-diagnostics-11-00834">
<span class="label">20.</span><cite>Garcia-Pavia P., Rapezzi C., Adler Y., Arad M., Basso C., Brucato A., Burazor I., Caforio A.L.P., Damy T., Eriksson U., et al.  Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. J. Heart Fail. 2021;42:1554–1568. doi: 10.1093/eurheartj/ehab072.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehab072" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8060056/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33825853/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Heart%20Fail.&amp;title=Diagnosis%20and%20treatment%20of%20cardiac%20amyloidosis.%20A%20position%20statement%20of%20the%20European%20Society%20of%20Cardiology%20Working%20Group%20on%20Myocardial%20and%20Pericardial%20Diseases&amp;author=P.%20Garcia-Pavia&amp;author=C.%20Rapezzi&amp;author=Y.%20Adler&amp;author=M.%20Arad&amp;author=C.%20Basso&amp;volume=42&amp;publication_year=2021&amp;pages=1554-1568&amp;pmid=33825853&amp;doi=10.1093/eurheartj/ehab072&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21-diagnostics-11-00834">
<span class="label">21.</span><cite>Fine N.M., Davis M.K., Anderson K., Delgado D.H., Giraldeau G., Kitchlu A., Massie R., Narayan J., Swiggum E., Venner C.P., et al.  Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients with Cardiac Amyloidosis. Can. J. Cardiol. 2020;36:322–334. doi: 10.1016/j.cjca.2019.12.034.</cite> [<a href="https://doi.org/10.1016/j.cjca.2019.12.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32145862/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can.%20J.%20Cardiol.&amp;title=Canadian%20Cardiovascular%20Society/Canadian%20Heart%20Failure%20Society%20Joint%20Position%20Statement%20on%20the%20Evaluation%20and%20Management%20of%20Patients%20with%20Cardiac%20Amyloidosis&amp;author=N.M.%20Fine&amp;author=M.K.%20Davis&amp;author=K.%20Anderson&amp;author=D.H.%20Delgado&amp;author=G.%20Giraldeau&amp;volume=36&amp;publication_year=2020&amp;pages=322-334&amp;pmid=32145862&amp;doi=10.1016/j.cjca.2019.12.034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22-diagnostics-11-00834">
<span class="label">22.</span><cite>Yilmaz A., Bauersachs J., Bengel F., Buchel R., Kindermann I., Klingel K., Klingel K., Knebel F., Meder B., Morbach C., et al.  Diagnosis and treatment of cardiac amyloidosis: Position statement of the German Cardiac Society (DGK) Clin. Res. Cardiol. 2021;110:479–506. doi: 10.1007/s00392-020-01799-3.</cite> [<a href="https://doi.org/10.1007/s00392-020-01799-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8055575/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33459839/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Res.%20Cardiol.&amp;title=Diagnosis%20and%20treatment%20of%20cardiac%20amyloidosis:%20Position%20statement%20of%20the%20German%20Cardiac%20Society%20(DGK)&amp;author=A.%20Yilmaz&amp;author=J.%20Bauersachs&amp;author=F.%20Bengel&amp;author=R.%20Buchel&amp;author=I.%20Kindermann&amp;volume=110&amp;publication_year=2021&amp;pages=479-506&amp;pmid=33459839&amp;doi=10.1007/s00392-020-01799-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23-diagnostics-11-00834">
<span class="label">23.</span><cite>Tanskanen M., Peuralinna T., Polvikoski T., Notkola I.L., Sulkava R., Hardy J., Singleton A., Kiuru-Enari S., Paetau A., Tienari P.J., et al.  Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: A population-based autopsy study. Ann. Med. 2008;40:232–239. doi: 10.1080/07853890701842988.</cite> [<a href="https://doi.org/10.1080/07853890701842988" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18382889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Med.&amp;title=Senile%20systemic%20amyloidosis%20affects%2025%%20of%20the%20very%20aged%20and%20associates%20with%20genetic%20variation%20in%20alpha2-macroglobulin%20and%20tau:%20A%20population-based%20autopsy%20study&amp;author=M.%20Tanskanen&amp;author=T.%20Peuralinna&amp;author=T.%20Polvikoski&amp;author=I.L.%20Notkola&amp;author=R.%20Sulkava&amp;volume=40&amp;publication_year=2008&amp;pages=232-239&amp;pmid=18382889&amp;doi=10.1080/07853890701842988&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24-diagnostics-11-00834">
<span class="label">24.</span><cite>González-López E., Gallego-Delgado M., Guzzo-Merello G., Moral F.J.D.H.-D., Cobo-Marcos M., Robles C., Bornstein B., Salas C., Lara-Pezzi E., Alonso-Pulpon L., et al.  Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur. Heart J. 2015;36:2585–2594. doi: 10.1093/eurheartj/ehv338.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehv338" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26224076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Wild-type%20transthyretin%20amyloidosis%20as%20a%20cause%20of%20heart%20failure%20with%20preserved%20ejection%20fraction&amp;author=E.%20Gonz%C3%A1lez-L%C3%B3pez&amp;author=M.%20Gallego-Delgado&amp;author=G.%20Guzzo-Merello&amp;author=F.J.D.H.-D.%20Moral&amp;author=M.%20Cobo-Marcos&amp;volume=36&amp;publication_year=2015&amp;pages=2585-2594&amp;pmid=26224076&amp;doi=10.1093/eurheartj/ehv338&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25-diagnostics-11-00834">
<span class="label">25.</span><cite>Hahn V.S., Yanek L.R., Vaishnav J., Ying W., Vaidya D., Lee Y.Z.J., Riley S.J., Subramanya V., Brown E.E., Hopkins C.D., et al.  Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis. JACC Heart Fail. 2020;8:712–724. doi: 10.1016/j.jchf.2020.04.007.</cite> [<a href="https://doi.org/10.1016/j.jchf.2020.04.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7604801/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32653448/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JACC%20Heart%20Fail.&amp;title=Endomyocardial%20Biopsy%20Characterization%20of%20Heart%20Failure%20With%20Preserved%20Ejection%20Fraction%20and%20Prevalence%20of%20Cardiac%20Amyloidosis&amp;author=V.S.%20Hahn&amp;author=L.R.%20Yanek&amp;author=J.%20Vaishnav&amp;author=W.%20Ying&amp;author=D.%20Vaidya&amp;volume=8&amp;publication_year=2020&amp;pages=712-724&amp;pmid=32653448&amp;doi=10.1016/j.jchf.2020.04.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26-diagnostics-11-00834">
<span class="label">26.</span><cite>Treibel T.A., Fontana M., Gilbertson J.A., Castelletti S., White S.K., Scully P.R., Roberts N., Hutt D.F., Rowczenio D.M., Whelan C.J., et al.  Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement. Circ. Cardiovasc. Imaging. 2016;9:e005066. doi: 10.1161/CIRCIMAGING.116.005066.</cite> [<a href="https://doi.org/10.1161/CIRCIMAGING.116.005066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27511979/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20Cardiovasc.%20Imaging&amp;title=Occult%20Transthyretin%20Cardiac%20Amyloid%20in%20Severe%20Calcific%20Aortic%20Stenosis:%20Prevalence%20and%20Prognosis%20in%20Patients%20Undergoing%20Surgical%20Aortic%20Valve%20Replacement&amp;author=T.A.%20Treibel&amp;author=M.%20Fontana&amp;author=J.A.%20Gilbertson&amp;author=S.%20Castelletti&amp;author=S.K.%20White&amp;volume=9&amp;publication_year=2016&amp;pages=e005066&amp;pmid=27511979&amp;doi=10.1161/CIRCIMAGING.116.005066&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27-diagnostics-11-00834">
<span class="label">27.</span><cite>Cavalcante J.L., Rijal S., Abdelkarim I., Althouse A.D., Sharbaugh M.S., Fridman Y., Soman P., Forman D.E., Schindler J.T., Gleason T.G., et al.  Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis. J. Cardiovasc. Magn. Reson. 2017;19:98. doi: 10.1186/s12968-017-0415-x.</cite> [<a href="https://doi.org/10.1186/s12968-017-0415-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5719789/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29212513/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cardiovasc.%20Magn.%20Reson.&amp;title=Cardiac%20amyloidosis%20is%20prevalent%20in%20older%20patients%20with%20aortic%20stenosis%20and%20carries%20worse%20prognosis&amp;author=J.L.%20Cavalcante&amp;author=S.%20Rijal&amp;author=I.%20Abdelkarim&amp;author=A.D.%20Althouse&amp;author=M.S.%20Sharbaugh&amp;volume=19&amp;publication_year=2017&amp;pages=98&amp;pmid=29212513&amp;doi=10.1186/s12968-017-0415-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28-diagnostics-11-00834">
<span class="label">28.</span><cite>Castano A., Narotsky D.L., Hamid N., Khalique O.K., Morgenstern R., DeLuca A., Rubin J., Chiuzan C., Nazif T., Vahl T., et al.  Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur. Heart J. 2017;38:2879–2887. doi: 10.1093/eurheartj/ehx350.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehx350" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5837725/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29019612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Unveiling%20transthyretin%20cardiac%20amyloidosis%20and%20its%20predictors%20among%20elderly%20patients%20with%20severe%20aortic%20stenosis%20undergoing%20transcatheter%20aortic%20valve%20replacement&amp;author=A.%20Castano&amp;author=D.L.%20Narotsky&amp;author=N.%20Hamid&amp;author=O.K.%20Khalique&amp;author=R.%20Morgenstern&amp;volume=38&amp;publication_year=2017&amp;pages=2879-2887&amp;pmid=29019612&amp;doi=10.1093/eurheartj/ehx350&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29-diagnostics-11-00834">
<span class="label">29.</span><cite>Scully P.R., Patel K.P., Treibel T.A., Thornton G.D., Hughes R.K., Chadalavada S., Katsoulis M., Hartman N., Fontana M., Pugliese F., et al.  Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation. Eur. Heart J. 2020;41:2759–2767. doi: 10.1093/eurheartj/ehaa170.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehaa170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7395329/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32267922/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Prevalence%20and%20outcome%20of%20dual%20aortic%20stenosis%20and%20cardiac%20amyloid%20pathology%20in%20patients%20referred%20for%20transcatheter%20aortic%20valve%20implantation&amp;author=P.R.%20Scully&amp;author=K.P.%20Patel&amp;author=T.A.%20Treibel&amp;author=G.D.%20Thornton&amp;author=R.K.%20Hughes&amp;volume=41&amp;publication_year=2020&amp;pages=2759-2767&amp;pmid=32267922&amp;doi=10.1093/eurheartj/ehaa170&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30-diagnostics-11-00834">
<span class="label">30.</span><cite>Maurer M.S., Schwartz J.H., Gundapaneni B., Elliott P.M., Merlini G., Waddington-Cruz M., Kristen A.V., Grogan M., Witteles R., Damy T., et al.  Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N. Engl. J. Med. 2018;379:1007–1016. doi: 10.1056/NEJMoa1805689.</cite> [<a href="https://doi.org/10.1056/NEJMoa1805689" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30145929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Tafamidis%20Treatment%20for%20Patients%20with%20Transthyretin%20Amyloid%20Cardiomyopathy&amp;author=M.S.%20Maurer&amp;author=J.H.%20Schwartz&amp;author=B.%20Gundapaneni&amp;author=P.M.%20Elliott&amp;author=G.%20Merlini&amp;volume=379&amp;publication_year=2018&amp;pages=1007-1016&amp;pmid=30145929&amp;doi=10.1056/NEJMoa1805689&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31-diagnostics-11-00834">
<span class="label">31.</span><cite>Coriu D.A.C., Talmaci R., Badelita S., Dobrea C., Murphy C.L. New transthyretin variant Glu54Gln associated with familial amyloidosis; Proceedings of the XIIIth International Symposium Amyloidosis Proceedings; Groningen, The Netherlands. 6–10 May 2012; pp. 357–360.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings%20of%20the%20XIIIth%20International%20Symposium%20Amyloidosis%20Proceedings&amp;title=New%20transthyretin%20variant%20Glu54Gln%20associated%20with%20familial%20amyloidosis&amp;author=D.A.C.%20Coriu&amp;author=R.%20Talmaci&amp;author=S.%20Badelita&amp;author=C.%20Dobrea&amp;author=C.L.%20Murphy&amp;pages=357-360&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32-diagnostics-11-00834">
<span class="label">32.</span><cite>Jercan A., Ene A., Jurcut R., Draghici M., Badelita S., Dragomir M., Dobrea C., Popescu M., Jardan D., Stoica E., et al.  Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population. Orphanet J. Rare Dis. 2020;15:34. doi: 10.1186/s13023-020-1309-9.</cite> [<a href="https://doi.org/10.1186/s13023-020-1309-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6993313/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32000831/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20J.%20Rare%20Dis.&amp;title=Clinical%20characteristics%20in%20patients%20with%20hereditary%20amyloidosis%20with%20Glu54Gln%20transthyretin%20identified%20in%20the%20Romanian%20population&amp;author=A.%20Jercan&amp;author=A.%20Ene&amp;author=R.%20Jurcut&amp;author=M.%20Draghici&amp;author=S.%20Badelita&amp;volume=15&amp;publication_year=2020&amp;pages=34&amp;pmid=32000831&amp;doi=10.1186/s13023-020-1309-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33-diagnostics-11-00834">
<span class="label">33.</span><cite>Gertz M., Adams D., Ando Y., Beirao J.M., Bokhari S., Coelho T., Comenzo R.L., Damy T., Dorbala S., Drachman B.M., et al.  Avoiding misdiagnosis: Expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner. BMC Fam. Pract. 2020;21:198.  doi: 10.1186/s12875-020-01252-4.</cite> [<a href="https://doi.org/10.1186/s12875-020-01252-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7513485/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32967612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Fam.%20Pract.&amp;title=Avoiding%20misdiagnosis:%20Expert%20consensus%20recommendations%20for%20the%20suspicion%20and%20diagnosis%20of%20transthyretin%20amyloidosis%20for%20the%20general%20practitioner&amp;author=M.%20Gertz&amp;author=D.%20Adams&amp;author=Y.%20Ando&amp;author=J.M.%20Beirao&amp;author=S.%20Bokhari&amp;volume=21&amp;publication_year=2020&amp;pages=198&amp;pmid=32967612&amp;doi=10.1186/s12875-020-01252-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34-diagnostics-11-00834">
<span class="label">34.</span><cite>Witteles R.M., Bokhari S., Damy T., Elliott P.M., Falk R.H., Fine N.M., Gospodinova M., Obici L., Rapezzi C., Garcia-Pavia P. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice. JACC Heart Fail. 2019;7:709–716. doi: 10.1016/j.jchf.2019.04.010.</cite> [<a href="https://doi.org/10.1016/j.jchf.2019.04.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31302046/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JACC%20Heart%20Fail.&amp;title=Screening%20for%20Transthyretin%20Amyloid%20Cardiomyopathy%20in%20Everyday%20Practice&amp;author=R.M.%20Witteles&amp;author=S.%20Bokhari&amp;author=T.%20Damy&amp;author=P.M.%20Elliott&amp;author=R.H.%20Falk&amp;volume=7&amp;publication_year=2019&amp;pages=709-716&amp;pmid=31302046&amp;doi=10.1016/j.jchf.2019.04.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35-diagnostics-11-00834">
<span class="label">35.</span><cite>Papoutsidakis N., Miller E.J., Rodonski A., Jacoby D. Time Course of Common Clinical Manifestations in Patients with Transthyretin Cardiac Amyloidosis: Delay from Symptom Onset to Diagnosis. J. Card. Fail. 2018;24:131–133. doi: 10.1016/j.cardfail.2017.12.005.</cite> [<a href="https://doi.org/10.1016/j.cardfail.2017.12.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29305186/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Card.%20Fail.&amp;title=Time%20Course%20of%20Common%20Clinical%20Manifestations%20in%20Patients%20with%20Transthyretin%20Cardiac%20Amyloidosis:%20Delay%20from%20Symptom%20Onset%20to%20Diagnosis&amp;author=N.%20Papoutsidakis&amp;author=E.J.%20Miller&amp;author=A.%20Rodonski&amp;author=D.%20Jacoby&amp;volume=24&amp;publication_year=2018&amp;pages=131-133&amp;pmid=29305186&amp;doi=10.1016/j.cardfail.2017.12.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36-diagnostics-11-00834">
<span class="label">36.</span><cite>Nakagawa M., Sekijima Y., Yazaki M., Tojo K., Yoshinaga T., Doden T., Koyama J., Yanagisawa S., Ikeda S. Carpal tunnel syndrome: A common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis. Amyloid. 2016;23:58–63. doi: 10.3109/13506129.2015.1135792.</cite> [<a href="https://doi.org/10.3109/13506129.2015.1135792" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26852880/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Carpal%20tunnel%20syndrome:%20A%20common%20initial%20symptom%20of%20systemic%20wild-type%20ATTR%20(ATTRwt)%20amyloidosis&amp;author=M.%20Nakagawa&amp;author=Y.%20Sekijima&amp;author=M.%20Yazaki&amp;author=K.%20Tojo&amp;author=T.%20Yoshinaga&amp;volume=23&amp;publication_year=2016&amp;pages=58-63&amp;pmid=26852880&amp;doi=10.3109/13506129.2015.1135792&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37-diagnostics-11-00834">
<span class="label">37.</span><cite>Cowan A.J., Skinner M., Berk J.L., Sloan J.M., O’Hara C., Seldin D.C., Sanchorawala V. Macroglossia-not always AL amyloidosis. Amyloid. 2011;18:83–86. doi: 10.3109/13506129.2011.560217.</cite> [<a href="https://doi.org/10.3109/13506129.2011.560217" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21401321/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Macroglossia-not%20always%20AL%20amyloidosis&amp;author=A.J.%20Cowan&amp;author=M.%20Skinner&amp;author=J.L.%20Berk&amp;author=J.M.%20Sloan&amp;author=C.%20O%E2%80%99Hara&amp;volume=18&amp;publication_year=2011&amp;pages=83-86&amp;pmid=21401321&amp;doi=10.3109/13506129.2011.560217&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38-diagnostics-11-00834">
<span class="label">38.</span><cite>Jurcut R., Onciul S., Adam R., Stan C., Coriu D., Rapezzi C., Popescu B.A. Multimodality imaging in cardiac amyloidosis: A primer for cardiologists. Eur. Heart J. Cardiovasc. Imaging. 2020;21:833–844. doi: 10.1093/ehjci/jeaa063.</cite> [<a href="https://doi.org/10.1093/ehjci/jeaa063" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32393965/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.%20Cardiovasc.%20Imaging&amp;title=Multimodality%20imaging%20in%20cardiac%20amyloidosis:%20A%20primer%20for%20cardiologists&amp;author=R.%20Jurcut&amp;author=S.%20Onciul&amp;author=R.%20Adam&amp;author=C.%20Stan&amp;author=D.%20Coriu&amp;volume=21&amp;publication_year=2020&amp;pages=833-844&amp;pmid=32393965&amp;doi=10.1093/ehjci/jeaa063&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39-diagnostics-11-00834">
<span class="label">39.</span><cite>Feng D., Edwards W.D., Oh J.K., Chandrasekaran K., Grogan M., Martinez M.W., Syed I.S., Hughes D.A., Lust J.A., Jaffe A.S., et al.  Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation. 2007;116:2420–2426. doi: 10.1161/CIRCULATIONAHA.107.697763.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.107.697763" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17984380/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Intracardiac%20thrombosis%20and%20embolism%20in%20patients%20with%20cardiac%20amyloidosis&amp;author=D.%20Feng&amp;author=W.D.%20Edwards&amp;author=J.K.%20Oh&amp;author=K.%20Chandrasekaran&amp;author=M.%20Grogan&amp;volume=116&amp;publication_year=2007&amp;pages=2420-2426&amp;pmid=17984380&amp;doi=10.1161/CIRCULATIONAHA.107.697763&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40-diagnostics-11-00834">
<span class="label">40.</span><cite>Bezard M., Kharoubi M., Galat A., Poullot E., Guendouz S., Fanen P., Funalot B., Moktefi A., Lefaucheur J.P., Abulizi M., et al.  Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis. Eur. J. Heart Fail. 2021;23:264–274. doi: 10.1002/ejhf.2028.</cite> [<a href="https://doi.org/10.1002/ejhf.2028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33094885/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Heart%20Fail.&amp;title=Natural%20history%20and%20impact%20of%20treatment%20with%20tafamidis%20on%20major%20cardiovascular%20outcome-free%20survival%20time%20in%20a%20cohort%20of%20patients%20with%20transthyretin%20amyloidosis&amp;author=M.%20Bezard&amp;author=M.%20Kharoubi&amp;author=A.%20Galat&amp;author=E.%20Poullot&amp;author=S.%20Guendouz&amp;volume=23&amp;publication_year=2021&amp;pages=264-274&amp;pmid=33094885&amp;doi=10.1002/ejhf.2028&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41-diagnostics-11-00834">
<span class="label">41.</span><cite>Adams D., Gonzalez-Duarte A., O’Riordan W.D., Yang C.C., Ueda M., Kristen A.V., Tournev I., Schmidt H.H., Coelho T., Berk J.L., et al.  Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis. N. Engl. J. Med. 2018;379:11–21. doi: 10.1056/NEJMoa1716153.</cite> [<a href="https://doi.org/10.1056/NEJMoa1716153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29972753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Patisiran,%20an%20RNAi%20Therapeutic,%20for%20Hereditary%20Transthyretin%20Amyloidosis&amp;author=D.%20Adams&amp;author=A.%20Gonzalez-Duarte&amp;author=W.D.%20O%E2%80%99Riordan&amp;author=C.C.%20Yang&amp;author=M.%20Ueda&amp;volume=379&amp;publication_year=2018&amp;pages=11-21&amp;pmid=29972753&amp;doi=10.1056/NEJMoa1716153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42-diagnostics-11-00834">
<span class="label">42.</span><cite>Benson M.D., Waddington-Cruz M., Berk J.L., Polydefkis M., Dyck P.J., Wang A.K., Plante-Bordeneuve V., Barroso F.A., Merlini G., Obici L., et al.  Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis. N. Engl. J. Med. 2018;379:22–31. doi: 10.1056/NEJMoa1716793.</cite> [<a href="https://doi.org/10.1056/NEJMoa1716793" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12611561/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29972757/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Inotersen%20Treatment%20for%20Patients%20with%20Hereditary%20Transthyretin%20Amyloidosis&amp;author=M.D.%20Benson&amp;author=M.%20Waddington-Cruz&amp;author=J.L.%20Berk&amp;author=M.%20Polydefkis&amp;author=P.J.%20Dyck&amp;volume=379&amp;publication_year=2018&amp;pages=22-31&amp;pmid=29972757&amp;doi=10.1056/NEJMoa1716793&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43-diagnostics-11-00834">
<span class="label">43.</span><cite>Palladini G., Milani P., Foli A., Vidus Rosin M., Basset M., Lavatelli F., Nuvolone M., Obici L., Perlini S., Merlini G. Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: A matched case-control study on 174 patients. Leukemia. 2014;28:2311–2316. doi: 10.1038/leu.2014.227.</cite> [<a href="https://doi.org/10.1038/leu.2014.227" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25059496/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Melphalan%20and%20dexamethasone%20with%20or%20without%20bortezomib%20in%20newly%20diagnosed%20AL%20amyloidosis:%20A%20matched%20case-control%20study%20on%20174%20patients&amp;author=G.%20Palladini&amp;author=P.%20Milani&amp;author=A.%20Foli&amp;author=M.%20Vidus%20Rosin&amp;author=M.%20Basset&amp;volume=28&amp;publication_year=2014&amp;pages=2311-2316&amp;pmid=25059496&amp;doi=10.1038/leu.2014.227&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/8148147/bin/diagnostics-11-00834-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (73.1KB, zip) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data presented in this study are available on request from the corresponding author.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Diagnostics are provided here courtesy of <strong>Multidisciplinary Digital Publishing Institute  (MDPI)</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3390/diagnostics11050834"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/diagnostics-11-00834.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (908.4 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/8148147/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/8148147/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8148147%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8148147/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC8148147/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC8148147/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/34066384/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC8148147/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/34066384/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC8148147/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/8148147/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="ADoJi1ImrJMkpW47AAfehZ33po6lF59tBmbqLM6yo51QJpnsOOkU5DvDacmViFQ7">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
